Search by Drug Name or NDC

    NDC 00310-6540-04 BYDUREON BCise 2 mg/.85mL Details

    BYDUREON BCise 2 mg/.85mL

    BYDUREON BCise is a SUBCUTANEOUS INJECTION, SUSPENSION, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AstraZeneca Pharmaceuticals LP. The primary component is EXENATIDE.

    Product Information

    NDC 00310-6540
    Product ID 0310-6540_745b5938-8834-45c4-a5f0-ba7c9e6628c6
    Associated GPIs 2717002000D420
    GCN Sequence Number 077890
    GCN Sequence Number Description exenatide microspheres AUTO INJCT 2MG/0.85ML SUBCUT
    HIC3 C4I
    HIC3 Description ANTIHYPERGLY,INCRETIN MIMETIC(GLP-1 RECEP.AGONIST)
    GCN 44039
    HICL Sequence Number 038451
    HICL Sequence Number Description EXENATIDE MICROSPHERES
    Brand/Generic Brand
    Proprietary Name BYDUREON BCise
    Proprietary Name Suffix n/a
    Non-Proprietary Name exenatide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SUSPENSION, EXTENDED RELEASE
    Route SUBCUTANEOUS
    Active Ingredient Strength 2
    Active Ingredient Units mg/.85mL
    Substance Name EXENATIDE
    Labeler Name AstraZeneca Pharmaceuticals LP
    Pharmaceutical Class GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA209210
    Listing Certified Through 2024-12-31

    Package

    NDC 00310-6540-04 (00310654004)

    NDC Package Code 0310-6540-04
    Billing NDC 00310654004
    Package 4 CARTRIDGE in 1 CARTON (0310-6540-04) / .85 mL in 1 CARTRIDGE (0310-6540-01)
    Marketing Start Date 2017-12-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 234.05
    Pricing Unit ML
    Effective Date 2024-01-01
    NDC Description BYDUREON BCISE 2 MG AUTOINJECT
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4, 5
    Classification for Rate Setting B
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis